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STUDY QUESTION: Did weight reduction in obese women scheduled for IVF increase cumulative live birth rate (CLBR) after 2 years?
SUMMARY ANSWER: Weight loss prior to IVF did not increase CLBR.
WHAT IS KNOWN ALREADY: Few studies have investigated the effect of weight reduction in obese infertile women scheduled for IVF.
In a recent randomized controlled trial (RCT), including one IVF cycle, we found no increase in live birth rate after weight reduction. Weight
regain after obesity reduction treatment often occurs, and children born to obese women have a higher risk of childhood obesity.
STUDY DESIGN, SIZE, DURATION: A 2-year follow-up of a multicenter, RCT running between 2012 and 2018 was performed. Out of
317 women randomized to weight reduction followed by IVF treatment or IVF treatment-only, 305 remained in the full analysis set. Of these
women, 90.5% (276/305) participated in this study.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Nine infertility clinics in Sweden, Denmark and Iceland participated in the RCT.
Obese women under 38 years of age having a BMI ≥30 and< 35 kg/m2 were randomized to weight reduction and IVF or IVF-only. In all, 160
patients were randomized to a low calorie diet for 12 weeks and 3–5 weeks of weight stabilization, before IVF and 157 patients to IVF-only.
Two years after randomization, the patients filled in a questionnaire regarding current weight, live births and ongoing pregnancies.
MAIN RESULTS AND THE ROLE OF CHANCE: 42 additional live births were achieved during the follow-up in the weight reduction
and IVF group, and 40 additional live births in the IVF-only group, giving a CLBR, the main outcome of this study, of 57.2% (87/152) and 53.6%
(82/153), respectively (P=0.56; odds ratio (OR) 1.16, 95% CI: 0.74–1.52). Most of the women in the weight reduction and IVF group had
regained their pre-study weight after 2 years. The mean weight gain over the 2 years was 8.6 kg, while women in the IVF-only group had a
mean weight loss of 1.2 kg. At the 2-year follow-up, the weight standard deviation scores of the children born in the original RCT (index cycle)
were 0.218 (1.329) (mean, SD) in the weight reduction and IVF group and− 0.055 (1.271) (mean, SD) in the IVF-only group (P=0.25; mean
difference between groups, 0.327; 95% CI: −0.272 to 0.932).
LIMITATIONS, REASON FOR CAUTION: All data presented in this follow-up study were self-reported by the participants, which could
affect the results. A further limitation is in power for the main outcome. The study is a secondary analysis of a large RCT, where the original
power calculation was based on live-birth rate after one cycle and not on CLBR.
WIDER IMPLICATIONS OF THE FINDINGS: The follow-up indicates that for women with a BMI ≥30 and< 35 kg/m2 and scheduled
for IVF, the weight reduction did not increase their chance of a live birth either in the index cycle or after 2 years. It also shows that even in this
highly motivated group, a regain of pre-study weight occurred.
STUDY FUNDING/COMPETING INTEREST(S): The 2-year follow-up was financed by grants from the Swedish state under
the agreement between the Swedish Government and the county councils, the ALF-agreement (ALFGBG-70940 and ALFGBG-77690),
Merck AB, Solna, Sweden (an affiliate of Merck KGaA, Darmstadt, Germany), Hjalmar Svensson Foundation. Ms Kluge has nothing to disclose.
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WHAT DOES THIS MEAN FOR PATIENTS?
This study looks at whether losing weight before In Vitro Fertilization (IVF) makes it more likely that very overweight (obese) women will have
a child within two years. Many earlier studies have shown that obese women have a reduced chance of having a child after IVF.
In our previous trial, infertile obese (women with a BMI—a measure of appropriate weight for their height of 30 or over and under 35 kg/m2)
women were divided into two groups: the first to a weight reduction program before starting IVF treatment and the second group started IVF
treatment immediately. Even though the women in the weight reduction group lost more than nine kilograms, they did not have more children
compared with the women who did not lose weight. In this study, we looked at these women 2 years after the first trial.
The women were given a questionnaire and almost all of the patients from the main study answered it. We found that over half of the women
in the weight reduction group had a child (57.2%), and the result was about the same for the other group (53.6%). At this point, the two groups
had a similar BMI.
This research shows that obese women who lose weight before IVF are not more likely to have a child in the following 2 years compared with
women who do not lose weight before IVF, and that most of the women who had lost weight had put it back on.
Introduction
Obesity has been shown to have a compromising effect on both
pregnancy and live birth rate for women undergoing ART, such as
IVF (Maheshwari et al., 2007; Luke et al., 2011; Bellver et al., 2013;
Petersen et al., 2013; Provost et al., 2016). When compared with
women with a normal BMI, obese women have an increased miscar-
riage rate and they require higher doses of gonadotrophins, illustrating
an impaired response to ovarian stimulation (Fedorcsak et al., 2004;
Metwally et al., 2008). A weight loss of 5–10% in obese women
has been demonstrated to be effective in normalizing menstruation,
ovulation and spontaneous pregnancy rates (Norman et al., 2004).
Earlier studies have shown that children born to obese women have
a higher risk for childhood obesity (Olson et al., 2010; Ruager-Martin
et al., 2010; Woo Baidal et al., 2016), and obese children have a higher
risk of adult adiposity, adult morbidity and premature mortality (Reilly
et al., 2011).
Until recently, only few studies (Moran et al., 2011; Sim et al., 2014;
Becker et al., 2015) have investigated the effect of weight reduction in
obese infertile women preceding infertility treatments. However, these
trials were not powered for pregnancy or live birth. A large Dutch
randomized controlled trial (RCT) found that life style interventions,
preceding fertility treatment, had no effect on cumulative live birth
rate (CLBR) after 24 months in infertile obese women, when including
ongoing pregnancies that ended after the follow-up period. The mean
weight loss in that study was modest, at 4.4 kg in the intervention group
and 1.1 kg in the control group, a difference between the groups of
3.3 kg (Mutsaerts et al., 2016). In our RCT where 317 obese women
(BMI ≥30 and <35 kg/m2) were randomized to weight reduction with
a low calorie diet (880 kcal/day) for 12weeks before IVF or to IVF-only,
we found no significant difference in live birth rate between groups
(Einarsson et al., 2017) although the mean weight change between the
groups was substantially higher at 9.44 kg.
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Weight regain after obesity reduction treatment is common and well
known. It is usually a challenge for the patient to maintain the new
lower weight (Franz et al., 2007; Kraschnewski et al., 2010; Johansson
et al., 2014), even though some studies show that weight maintenance
is possible (Vogels et al., 2007; Montesi et al., 2016). Little is known
about weight maintenance after weight reduction using a low calorie
diet specifically preceding an IVF treatment.
The aim of this follow-up study was to evaluate if weight reduction
in obese women scheduled for IVF increased the CLBR rates assessed
as having at least one live birth during a period of 2 years after
randomization and if the achieved weight reduction remained.
We alsowanted to evaluate if a largeweight loss in thewomenwould
affect the weight development of the children born in the index cycle,
i.e. the cycle included in the RCT.
Materials and Methods
The present studywas a 2-year follow-up of a prospective, multicentre,
RCT, performed between 2010 and 2016 in the Nordic countries
(Einarsson et al., 2017). A total of 317 obese infertile women under
38 years of age were randomized to two groups: weight reduction
and IVF or IVF-only. The weight reduction and IVF group started with
12 weeks of low calorie diet (880 kcal/day) and thereafter 2–5 weeks
of re-introduction to solid foods before IVF. The IVF-only group started
the IVF as soon as possible after randomization and was not given any
dietary counselling. In the full analysis set (FAS) population (n=305),
there was no significant difference regarding live birth between the
two groups: 29.6% (45/152) in the weight reduction and IVF group
and 27.5% (42/153) in the IVF-only group, but the women in the
intervention group had significantly more spontaneously conceived
pregnancies.
Knowing the risk of weight regain, the women in the weight reduc-
tion and IVF group were offered complementary dietary counselling by
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the dietician for 1 year from randomization, to help them to maintain
their achieved lower weight.
In the follow-up study, a questionnaire was sent, 2 years after
randomization, to all patients in the FAS population. The follow-up was
performed from 2012 to 2018. The questionnaire covered the current
weight of the woman at 2 years after randomization and if she had any
pregnancies or live births after the index cycle in the randomized trial.
The questionnaire also covered general health, last measured weight
and height of the children born in the RCT and data of the children
born after the RCT (birth date, mode of conception). The follow-up
questionnaire did not contain any questions concerning current or past
diet.
The primary outcome was CLBR in the FAS population, defined as at
least one child born alive, after infertility treatment or a spontaneous
pregnancy, during the 2-year follow-up from randomization, and to
assess if the weight reduction that was achieved remained at the
2-year follow-up. The time of 2 years made it possible to include
frozen embryo transfers (FETs) from the index cycle and additional IVF
or other fertility treatments performed during the follow-up period.
Furthermore, the risk of patients not answering a questionnaire was
anticipated to be low after a period of 2 years.
Secondary outcomes were ongoing pregnancies and a total number
of fertility treatments. Data concerning the number of treatments
were retrieved from patient records. Dietary-related measurements
included weight change between last weight measured in the RCT and
weight reported at the 2-year follow-up. A further secondary outcome
was follow-up of the children born in the index cycle concerning
general health, and weight and height measured at last visit at the Child
Health Care Centre.
Statistics
The main analysis in the present study was performed on the FAS pop-
ulation. Twenty-nine women in the FAS population did not participate
in the follow-up. Of these, six women in the weight reduction and IVF
group and three women in the IVF-only group had achieved a live birth
in the index cycle. Except for these births, we assumed that the women
who did not participate in the follow-up had not succeeded in having a
live birth.
The weights of the women with ongoing pregnancies at the time
of the follow-up were excluded from the weight calculations. One
woman (in the IVF-only group) answered the questionnaire during the
postpartum period, while all other women had passed this period at
time of follow-up. There are missing data concerning any additional
IVF/FET performed at one Danish clinic, and we have assumed that
these patients did not undergo any further treatments. There are also
missing data concerning follow-up weight for children born in the index
cycle andmissing data concerning weight of somewomen at the follow-
up. These patients were not included in the weight calculations. No
imputations were performed.
Descriptive statistics are given by mean, SD, median, maximum and
minimum for continuous variables and number and percentage for
categorical variables. For comparison between the two randomized
groups, Fisher’s exact test was used (lowest 1-sided P-value multiplied
by 2) for all dichotomous variables, the Mantel-Haenszel Chi Square
test was used for ordered categorical variables, Chi Square test was
used for non-ordered categorical variables and the Mann-Whitney
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U-test was used for continuous variables. The CI for dichotomous
variables was the unconditional exact confidence limits. If no exact
limits could be computed, the asymptotic Wald confidence limits with
continuity correction was calculated instead. The CI for the mean
difference between groups was based on Fisher’s non-parametric per-
mutation test. Weight standard deviation scores (SDS) were calculated
according to Marsal et al. (1996).
A P-value less than 0.05 or a 95% CI not including 1.0 was considered
significant.
According to a post hoc power calculation, it was possible to detect
a difference in cumulative live birth of 15% between groups, when 152
and 153 women were included in the two groups (α =0.05, β =0.20).
Data were analyzed using SPSS version 22.0 (IBM Corp, Armonk, NY,
USA).
Ethical approval
Research ethics committees in Sweden, Denmark and Iceland
approved the trial. All participants provided written informed consent
for the 2-year follow-up.
Results
From the FAS population, 90.5% (276/305) of the patients partic-
ipated in the follow-up: 137/152 in the weight reduction and IVF
group and 139/153 in the IVF-only group. The patient’s characteris-
tics were comparable in the two groups except for the termination
of pregnancy, which was significantly higher in the IVF-only group
(Table I). Forty-two additional live births were achieved during the
follow-up in the weight reduction and IVF group and 40 additional live
births in the IVF-only group, giving a CLBR of 57.2% (87/152) and
53.6% (82/153), respectively (P=0.56; odds ratio (OR) 1.16, 95% CI:
0.74–1.52).
In addition, one women in the intervention group had a second child,
and a further 19 ongoing pregnancies were reported in the weight
reduction and IVF group and 16 in the IVF-only group, including both
first pregnancies and pregnancies after a previous live birth (Table II).
In total, in the weight reduction and IVF group and the IVF-only group,
63.8% (97/152) and 58.2% (89/153), respectively, achieved a live birth
or first ongoing pregnancy (P=0.34; OR 1.28, 95% CI: 0.8–2.01). The
pregnancies achieved after the index cycle were the result of either new
fresh IVF treatments, FET, spontaneous conceptions, egg donation or
low-dose gonadotrophin treatment (Table II).
In total, 214 IVF/ICSI fresh treatments were performed in the weight
reduction and IVF group and 244 in the IVF-only group, and 70 and 74
FET cycles, respectively.
The majority of women in the weight reduction and IVF group
had regained their pre-study weight after 2 years with a mean weight
gain of 8.6 kg, while women in the IVF-only group had a mean
weight loss of 1.2 kg, P< 0.0001 (Fig. 1; Table III). The opportunity
for complementary dietary counselling by a dietician in the year after
randomizationwas utilized by 48% of the patients (21%; 4–7 visits, 27%;
1–3 visits, 52%; no visits). In the weight reduction and IVF group, 23.3%
(27/116) had a BMI <30 kg/m2 at the 2-year follow-up, compared
with 10.9% (13/119) in the IVF-only group (P=0.019). However, the
mean BMI did not differ between the groups at the 2-year follow-up
(Table III).
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Table I Characteristics of the patients in the 2-year follow-up.
Variable Weight reduction
intervention and IVF
(n=137)
IVF only (n = 139) p-value
.........................................................................................................................................................................................
Age of the woman at randomization (years) 31.6 (4.3) 32.0 (22.3; 38.0) 31.6 (4.2) 31.8 (22.7; 38.0) 0.97
Weight at randomization (kg) 92.8 (8.1) 92.1 (74.3; 111) 91.6 (8.0) 91.6 (73.1; 114.7) 0.35
BMI (kg/m2) at randomization 33.1 (1.4) 33.4 (29.9; 35.1) 33.0 (1.4) 33.3 (30; 35.1) 0.95
Duration of infertility (months) 38.2 (24.5) 30.0 (6.0; 168.0) 38.9 (21.7) 36.0 (1.0; 180.0) 0.22
Cause for infertility
Tubal factor 12 (8.8) 11 (7.9)
Endometriosis 6 (4.4) 2 (1.4)
Hormonal factor 2 (1.5) 9 (6.5)
Polycystic ovary syndrome 33 (24.1) 28 (20.1)
Male factor 43 (31.4) 41 (29.5)
Unexplained infertility 39 (28.5) 44 (31.7)
Other 2 (1.5) 4 (2.9) 0.24
Smoking 16 (11.7) 12 (8.6) 0.52
Ethnicity
Caucasian 127 (92.7) 128 (92.1)
African 1 (0.7) 2 (1.4)
Asian 2 (1.5) 2 (1.4)
Other 7 (5.1) 7 (5.0) 0.96
History of previous pregnancies
Live birth 9 (6.6) 10 (7.2) 1.00
Miscarriage 7 (5.1) 7 (5.0) 1.00
Termination of pregnancy 11 (8.0) 28 (20.1) 0.006
Ectopic pregnancy 0 (0.0) 3 (2.2) 0.25
History of previous treatment with IVF
0 113 (82.5) 117 (84.2)
1 13 (9.5) 14 (10.1)
2 11 (8.0) 8 (5.8) 0.56
For categorical variables, n (%) is presented. For continuous variables, Mean (SD)/Median (Min; Max) is presented. For comparison between groups, Fisher’s Exact test (lowest 1-sided
p-value multiplied by 2) was used for dichotomous variables, the Mantel-Haenszel Chi Square test was used for ordered categorical variables, Chi Square test was used for non-ordered
categorical variables and the Mann-Whitney U-test was used for continuous variables.
At the 2-year follow-up, the weight SDS for the children born in
the index cycle was 0.218 (1.329) (mean, SD) in the weight reduction
and IVF group and−0.055 (1.271) (mean, SD) in the IVF-only group
(P=0.25; mean difference between groups, 0.327; 95% CI −0.272 to
0.932) (Fig. 2; Table IV). The children born in the index cycle were
generally healthy at the 2-year follow-up. Adverse medical conditions
were reported for four children in the weight reduction and IVF group,
while in the IVF-only group, two children were affected.
Discussion
In this 2-year follow-up of a RCT, no significant difference in CLBR was
observed between the weight reduction and IVF group compared with
the IVF-only group. It also showed that most of the women in the
weight reduction and IVF group had regained their pre-study weight.
We found no difference in weight SDS development between children
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born in the RCT despite a considerable difference in maternal weight
between groups.
Our results are in line with the results of Mutsaerts et al., (2016),
where no difference in live birth rate was shown after a lifestyle
intervention preceding infertility treatment, when including ongoing
pregnancies that ended after the follow-up period. Mutsaerts discussed
that a larger weight loss might have led to a higher live birth rate, and
in our study, the difference in weight loss was almost three times as
large, at 9.44 kg compared with 3.3 kg in the Dutch study. Despite this
difference in weight loss, the CLBR in the present study did not differ
significantly between groups, although the 95% CI for OR of CLBR
indicated that clinical valuable differences between groups may exist.
Several studies have shown that it is common to regain lost weight
after a low calorie diet (Franz et al., 2007; Kraschnewski et al., 2010;
Johansson et al., 2014). This was confirmed in our 2-year follow-
up, where most women in the weight reduction and IVF group had
regained the weight lost during the intervention. Our hypothesis before
D
ow
nloaded from
 https://academ
ic.oup.com
/hropen/article-abstract/2019/4/hoz030/5648101 by D
anish R
egions user on 01 M
ay 2020
No increase in IVF birth rate at 2 years after weight loss 5
Table II Outcome of the FAS population at the 2-year follow-up.
Weight reduction and IVF
group
IVF only group p-value odds ratio
(95%CI)
.........................................................................................................................................................................................
Cumulative live birth rate∗ 87/152 (57.2) 82/153 (53.6) 0.56 1.16 (0.74 to 1.52)
No. of participants in the follow-up 137 139
No. of additional live births after
index cycle
42 40
Additional live birth rate 42/137 (30.7) 40/139 (28.8)
Way of conception
IVF/ICSI 20/42 (47.6) 20/40 (50)
FET 11/42 (26.2) 9/40 (22.5)
Spontaneous pregnancies 9/42 (21.4) 9/40 (22.5)
Oocyte donation/ 1/42 (2.4) 0 (0.0)
Gonadotrophin stimulation 1/42 (2.4) 0 (0.0)
Unknown 0 (0.0) 2/40 (5.0)
Ongoing pregnancies 19 16
- Expecting first child in the study 10/137 (7.3) 7/139 (5.0)
- Expecting second child in the study 9/137 (6.6) 9/139 (6.5)
Way of conception
IVF/ICSI 6/19 (31.6) 4/16 (25.0)
FET 4/19 (21.1) 1/16 (6.3)
Spontaneous pregnancy 9/19 (47.4) 9/16 (56.3)
Oocyte donation/ 0 (0.0) 1/16 (6.3)
Unknown 0 (0.0) 1/16 (6.3)
Cumulative live birth rate/ongoing
pregnancy rate
97/152 (63.8) 89/153 (58.2) 0.34 1.28 (0.8 to 2.01)
Total no. of started IVF/ICSI cycles∗∗ 214 244
Total no. of FET∗∗ 70 74
FAS: full analysis set, FET: frozen embryo transfer.
For categorical variables, n (%) is presented.
For comparison between groups, Fisher’s Exact test (lowest 1-sided p-value multiplied by 2) was used for dichotomous variables.
∗Cumulative live birth defined as at least one child born alive. Calculated on all FAS patients 152/153.
∗∗Missing data from one Danish clinic concerning any follow-up treatments performed by the nine patients in the weight reduction and IVF group and the seven patients from the IVF-only
group.
Table III Weight changes at 2-year follow-up, excluding ongoing pregnant women at the time for the follow up.
Weight reduction and IVF
group n=116
IVF only group n=119 p-value
.........................................................................................................................................................................................
Weight change from last assessment
in the RCT until 2 year follow up∗
8.57 (9.55) 8.40 (−33.50; 30.60) −1.18 (7.05) -0.60 (−29.10; 16.60) <0.0001
BMI (kg/m2) at 2 year follow up∗ 32.5 (3.5) 33.2 (22.7; 39.1) 33.1 (3.0) 33.3 (23.7; 42.2) 0.44
- No. of women with BMI <30 at the
2 year follow up
27 (23.1) 13 (10.9) 0.019
- No. of women with BMI ≥30—<34.9
at the 2 year follow up
52 (44.4) 70 (58.8) 0.044
- No. of women with BMI ≥35 at the
2 year follow up
37 (32.5) 36 (30.3) 0.895
For categorical variables, n (%) is presented. For continuous variables, Mean (SD)/Median (Min; Max) is presented. For comparison between groups, the Fisher’s Exact test (lowest
1-sided p-value multiplied by 2) was used for dichotomous variables and the Mann-Whitney U-test was used for continuous variables.
∗Missing weight data of two patients in the weight reduction and IVF group and four patients in the IVF-only group.
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Figure 1 Weight of women from randomization until 2-year follow-up.Visit 5 =week 15 of the diet. Visit 8 = oocyte retrieval. Missing data
visit 5, on 14 patients in the weight reduction and IVF group. Missing data visit 8, on 16 patients in the weight reduction and IVF group and 12 patients in
the IVF only group. Excluding ongoing pregnant women at the 2-year follow-up. Missing data, at the 2-year follow-up on two patients from the weight
reduction and IVF group and four patients from the IVF-only group.
Table IV Follow-up of children born in the index cycle (FAS live births excluding one set of twins).
Variable Weight reduction and IVF
group n=45
IVF only group n=41 p-value Mean difference
between groups
(95% CI)
.........................................................................................................................................................................................
Female 25 (55.6) 22 (53.7) 1.00
Birth weight (g) 3486 (523) 3560 (1820; 4384) 3584 (509) 3638 (2140; 4820) 0.46
Weight standard deviation
score at birth
−0.021 (0.868)
-0.050 (−1.615; 1.571)
0.073 (1.073) 0.061 (−2.605; 2.282) 0.61 0.104 (−0.332; 0.526)
Weight standard deviation
score 2 year visit∗
0.218 (1.329)
0.245 (−1.986; 4.241)
−0.055 (1.271)
-0.258 (−1.973; 3.530)
0.25 0.327 (−0.272; 0.932)
For categorical variables, n (%) is presented. For continuous variables, Mean (SD)/Median (Min; Max)/n= is presented. For comparison between groups, Fisher’s Exact test (lowest 1-
sided p-value multiplied by 2) was used for dichotomous variables and the Mann-Whitney U-test was used for continuous variables. The CI for dichotomous variables is the unconditional
exact confidence limits. If no exact limits can be computed, the asymptotic Wald confidence limits with continuity correction are calculated instead. The CI for the mean difference
between groups is based on Fishers non-parametric permutation test.
∗Six women in the weight reduction and IVF group and three in the IVF-only group, who had a live birth in the index cycle, did not participate in the follow-up. Missing weight data at the
2-year follow-up: three in the weight reduction and IVF group and two in the IVF-only group.
the study was that the women in this highly motivated group of
patients, performing IVF-treatments, might be able to keep the lower
post-study weight in order to improve outcome.
However, significantly more women in the weight reduction and IVF
group had a BMI< 30 kg/m2 at the 2-year follow-up: 23.3% (27/116)
compared with 10.9% (13/119) the IVF-only group (P=0.019).
It is well known that children born to obese women have a higher
risk of childhood obesity (Olson et al., 2010; Woo Baidal et al., 2016)
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
and that obese children have a higher risk of adult adiposity, adult
morbidity and premature mortality (Reilly et al., 2011). At the present
2-year follow-up, there was no significant difference between the
groups in weight SDS of the children born in the index cycle, despite a
considerable difference in maternal weight (Fig. 2; Table IV).
The strength of this follow-up study is the high participation rate of
above 90%. Another strength is that the study is a follow-up of a RCT
in a field that is quite difficult to explore.
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Figure 2 Weight SDS of children born in the index cycle.
SDS: standard deviation scores. Each child is represented by one dot.
A limitation is that data are self-reported by questionnaires, yet a
recently published study showed that bias in self-reported weight is
negligible (Seijo et al., 2018). It is a challenge to assess weight in this
group of women. They might recently have given birth or are still
pregnant at the time of assessment. We chose to exclude women with
ongoing pregnancies when presenting data on the weights at the 2-year
follow-up. No weight assessment was made during the follow-up time,
and therefore, we have no data concerning when the women regained
the lost weight, which is a limitation. Although 90.5% of the women in
the RCT participated in the follow-up, it is obviously a limitation that
not all women participated.
There is also some limitation in power to detect clinical differences in
CLBR. One could argue that even a smaller difference in CLBR would
be valuable for the patient. However, we believe that a rather large
difference in CLBR is required to motivate young women to participate
in a rather demanding trial, which this 2-year follow-up is based on. This
statement is well supported by the randomization process in the main
RCT, indicating a high decline rate. Thus, we consider the power in the
present study as reasonable.
In conclusion, no significant difference in CLBR between the groups
at the 2-year follow-up was observed. Most patients in the weight
reduction and IVF group had regained the weight they lost during the
weight reduction. There was no difference at the follow-up between
the groups in weight SDS for the children born in the index cycle. The
follow-up indicated that for women scheduled for IVF showing World
Health Organization class I obesity (BMI ≥30 and< 35 kg/m2), the
weight reduction did not increase their chance of a live birth either
in the index cycle or after 2 years. It also shows that even in this highly
motivated group, a regain of pre-study weight occurred.
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